COVID-19 Disease
📧 Sign up to get email alerts when something new happens for COVID-19 Disease.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-08-26EMA Authorised: Spikevax (previously COVID-19 Vaccine Moderna) (single-stranded, 5’-capped messenger RNA (mRNA) produced using a cell-free in vitro transcription from the corresponding DNA templates, encoding the viral spike (S) protein of SARS-CoV-2) — Moderna Biotech Spain, S.L.
The EMA has authorised Spikevax (Moderna) for use in the EU; it is an mRNA vaccine encoding the SARS-CoV-2 spike protein for COVID-19.
-
EMA approval · 2026-07-24EMA Authorised: Comirnaty (single-stranded, 5’-capped messenger RNA produced using a cell-free in vitro transcription from the corresponding DNA templates, encoding the viral spike (S) protein of SARS-CoV-2) — BioNTech Manufacturing GmbH
EMA authorises Comirnaty (BioNTech) for COVID-19 virus infection as a vaccine based on mRNA technology.
-
EMA approval · 2026-07-13EMA Authorised: Paxlovid (nirmatrelvir;ritonavir) — Pfizer Europe MA EEIG
EMA authorised Paxlovid (nirmatrelvir/ritonavir) for COVID-19 virus infection in Europe.